We are live on ! Find out more
Citigroup

Citigroup Portfolio holdings

AUM $235B
1-Year Est. Return 32.99%
 

Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.

This Fund
S&P 500
This Quarter Est. Return
+0.54%
1 Year Est. Return
+32.99%
3 Year Est. Return
+97.19%
5 Year Est. Return
+117.91%
10 Year Est. Return
+456.21%
AUM
$126B
AUM Growth
+$2.34B
Cap. Flow
+$2.62B
Cap. Flow %
2.07%
Top 10 Hldgs %
21.09%
Holding
8,008
New
182
Increased
3,096
Reduced
3,760
Closed
268

Sector Composition

Rank Sector Weight
1 Technology 6.16%
2 Financials 5.29%
3 Healthcare 5.26%
4 Consumer Discretionary 4.52%
5 Communication Services 3.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCPL
6826
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
$13K ﹤0.01%
1,250
-1,175
-48% -$12.8K
MTEM
6827
DELISTED
Molecular Templates, Inc.
MTEM
$13K ﹤0.01%
128
-180
-58% -$16.8K
MNRL
6828
DELISTED
Brigham Minerals, Inc. Class A Common Stock
MNRL
$13K ﹤0.01%
678
-4,745
-87% -$97.7K
GBL
6829
DELISTED
GAMCO Investors, Inc.
GBL
$13K ﹤0.01%
670
-1,549
-70% -$29.7K
AVH
6830
DELISTED
AVIANCA HOLDINGS S.A.
AVH
$13K ﹤0.01%
+3,625
New +$12.8K
ROX
6831
DELISTED
Castle Brands, Inc.
ROX
$13K ﹤0.01%
10,399
-3,492
-25% -$2.82K
ABUS icon
6832
Arbutus Biopharma
ABUS
$873M
$12K ﹤0.01%
7,928
-4,985
-39% -$8.59K
ACET icon
6833
Adicet Bio
ACET
$75.3M
$12K ﹤0.01%
12
-30
-71% -$33.5K
AIVI icon
6834
WisdomTree International AI Enhanced Value Fund
AIVI
$60.7M
$12K ﹤0.01%
300
AKBA icon
6835
CALL
Akebia Therapeutics
AKBA
$335M
$12K ﹤0.01%
2,997
BCLI
6836
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$12K ﹤0.01%
197
+184
+1,415% +$10.9K
CLPR
6837
Clipper Realty
CLPR
$47M
$12K ﹤0.01%
1,201
-3,323
-73% -$36.4K
CRD.A icon
6838
Crawford & Co Class A
CRD.A
$551M
$12K ﹤0.01%
1,107
-3,796
-77% -$38.9K
DGS icon
6839
WisdomTree Emerging Markets SmallCap Dividend Fund
DGS
$1.69B
$12K ﹤0.01%
271
ESGU icon
6840
iShares ESG Aware MSCI USA ETF
ESGU
$17.8B
$12K ﹤0.01%
176
+20
+13% +$1.3K
FTK icon
6841
CALL
Flotek Industries
FTK
$852M
$12K ﹤0.01%
900
-1,567
-64% -$23.9K
GCBC icon
6842
Greene County Bancorp
GCBC
$575M
$12K ﹤0.01%
852
-968
-53% -$13.3K
GRX
6843
Gabelli Healthcare & Wellness Trust
GRX
$144M
$12K ﹤0.01%
1,130
IFGL icon
6844
iShares International Developed Real Estate ETF
IFGL
$83M
$12K ﹤0.01%
389
JRI icon
6845
Nuveen Real Asset Income & Growth Fund
JRI
$355M
$12K ﹤0.01%
697
-615
-47% -$10.4K
JYNT icon
6846
The Joint Corp
JYNT
$123M
$12K ﹤0.01%
648
-3,010
-82% -$55.7K
LFT
6847
Lument Finance Trust
LFT
$42.5M
$12K ﹤0.01%
3,481
RJET
6848
Republic Airways Holdings
RJET
$854M
$12K ﹤0.01%
119
-250
-68% -$30.4K
NUBD icon
6849
Nuveen ESG US Aggregate Bond ETF
NUBD
$466M
$12K ﹤0.01%
476
+231
+94% +$5.92K
OGI
6850
Organigram Holdings
OGI
$132M
$12K ﹤0.01%
840
+510
+155% +$10.7K

Similar funds

Citigroup's Q3 2019 Portfolio in Review

As of Q3 2019, Citigroup held 8,008 positions worth $126B, up 1.9% from $124B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Citigroup's Q3 2019 filing shows 182 new, 3,096 increased, 3,760 reduced and 268 closed positions. Its largest new stake was Global X Genomics & Biotechnology ETF: 187,500 shares worth $9.38M. The largest sale was iShares Russell 1000 Value ETF, an estimated $2.49B.

By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 6.8% a quarter earlier, followed by Financials and Healthcare.

  • Citigroup's largest Q3 2019 buy was Global X Genomics & Biotechnology ETF: 187,500 shares worth $9.38M.
  • Citigroup added most to State Street SPDR S&P 500 ETF Trust in Q3 2019, an estimated $1.26B increase.
  • Citigroup's biggest Q3 2019 reduction was iShares Russell 1000 Value ETF, cutting an estimated $2.49B.
  • Citigroup fully exited Red Hat Inc in Q3 2019, selling an estimated $311M.
  • Citigroup's ten largest holdings make up 21% of its $126B portfolio in Q3 2019.
  • Citigroup opened 182 new positions and closed 268 in Q3 2019.
  • Citigroup's portfolio value rose 1.9% quarter-over-quarter to $126B.

Based on Citigroup's 13F filing for Q3 2019, filed 8 Nov 2019.